Polysiphonia japonica extract suppresses the Wnt/β-catenin pathway in colon cancer cells by activation of NF-κB

International Journal of Molecular Medicine

Volumn 17, Issue 6, 2006, Pages 1005-1010

  Gwak, Jungsug ^a   Park, Seoyoung ^a   Cho, Munju ^a   Song, Taeyun ^a   Cha, Seon Heui ^b   Kim, Dong Eun ^c   Jeon, You Jin ^b   Shin, Jae Gook ^a   Oh, Sangtaek ^a  

^a Inje University   (South Korea)

^b Jeju National University   (South Korea)

^c Dong Eui University   (South Korea)

Author keywords

Colon cancer; Nuclear factor B; Polysiphonia japonica; Wnt catenin pathway

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; BIOLOGICAL PRODUCT; CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; WNT PROTEIN;

ARTICLE; CELL CULTURE; COLON TUMOR; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM;

ANTICARCINOGENIC AGENTS; BETA CATENIN; BIOLOGICAL PRODUCTS; COLONIC NEOPLASMS; CYCLIN D1; DOWN-REGULATION; HUMANS; NF-KAPPA B; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; WNT PROTEINS;

EID: 33745727521     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.6.1005     Document Type: Article

References (32)

1. Miller JR: The Wnts. Genome Biol 3: 3001.1-3001.15, 2001.
2. Korinek V, Barker N, Morin PJ, Van Wichen D, De Weger R, Kinzler KW, Vogelstein B and Clevers H: Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science 275: 1784-1787, 1997.
3. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790, 1997.
4. Lee E, Salic A, Kruger R, Heinrich R and Kirschner MW: The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 1: 116-132, 2003.
5. Dominguez I and Green JB: Dorsal downregulation of GSK3β by a non-Wnt-like mechanism is an early molecular consequence of cortical rotation in early Xenopus embryos. Development 127: 861-868, 2000. (Pubitemid 30129032)
6. Polakis P: Casein kinase 1: a Wnt'er of disconnect. Cur Biol 12: R499-R501, 2002.
7. Giles RH, Van Es JH and Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24, 2003.
8. Matsuzawa SI and Reed JC: Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol Cell 7: 915-926, 2001.
9. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL and Matsunami N: Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7: 927-936, 2001.
10. Fearnhead NS, Britton MP and Bodmer WF: The ABC of APC. Hum Mol Genet 10: 721-733, 2001.
11. Morin PJ: β-catenin signaling and cancer. Bioessays 21: 1021-1030, 1999.
12. Orford K, Crockett C, Jensen JP, Weissman AM and Byers SW: Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J Biol Chem 272: 24735-24738, 1997. (Pubitemid 27415637)
13. Aberle H, Bauer A, Stappert J, Kispert A and Kemler R: β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804, 1997.
14. Tetsu O and McCormick F: β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999. (Pubitemid 29180374)
15. He TC, Sparks AB, Rago C, Hermeking H, Da Costa LT, Zawel L, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998.
16. Takahashi M, Tsunoda T, Seiki M, Nakamura Y and Furukawa Y: Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21: 5861-5867, 2002.
17. He TC, Chan TA, Vogelstein B and Kinzler KW: PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345, 1999. (Pubitemid 29519912)
18. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ and Yang Y: Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation. J Cell Biol 162: 899-908, 2003.
19. Klein PS and Melton DA: A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 94: 10330-10334, 1996.
20. Verma UN, Surabhi RM, Schmaltieg A, Becerra C and Gaynor RB: Small interfering RNAs directed against β-catenin inhibits the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 9: 1291-1300, 2003.
21. Roh H, Green DW, Boswell CB, Pippin JA and Drebin JA: Suppression of β-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res 61: 6563-6568, 2001.
22. Utsunomiya T, Doki Y, Takemoto H, Shiozaki H, Yano M, Sekimoto M, Tamura S, Yasuda T, Fujiwara Y and Monden M: Correlation of β-catenin and cyclin D1 expression in colon cancers. Oncology 61: 226-233, 2001.
23. Amson RB, Nemani M, Roperch JP, Israeli D, Bougueleret L, LeGall I, Medhioub M, Linares-Cruz G, Lethrosne F, Pasturaud P, Piouffre L, Prieur S, Susini L, Alvaro V, Millasseau P, Guidicelli C, Bui H, Massart C, Cazes L, Bruzzoni-Giovanelli H, Dufour F, Owadi H, Hennion C, Charpak G, Telerman A, et al: Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the Drosophila seven in absentia gene. Proc Natl Acad Sci USA 93: 3953-3957, 1996.
24. Cho M, Gwak J, Park S, Won J, Kim DE, Yea SS, Cha IJ, Kim TK, Shin JG and Oh S: Diclofenac attenuates Wnt/β-catenin signaling in colon cancer cells by activation of NF-κB. FEBS Lett 579: 4213-4218, 2005.
25. Ghosh S, May MJ and Kopp EB: NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998.
26. Gilmore TD, Koedood M, Piffat KA and White DW: Rel/NF-κB/IκB proteins and cancer. Oncogene 13: 1367-1378, 1996.
27. Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V and Merville MP: Nuclear factor-κB, cancer, and apoptosis. Biochem Pharmacol 60: 1085-1089, 2000.
28. Karim R, Tse G, Putti T, Scolyer R and Lee S: The significance of the Wnt pathway in the pathology of human cancers. Pathology 36: 120-128, 2004.
29. Baeuerle PA and Baltimore D: IκB: a specific inhibitor of the NF-κB transcription factor. Science 242: 540-546. 1998.
30. Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F and Ben-Neriah Y: Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396: 590-594, 1998.
31. Sadot E, Conacci-Sorrell M, Zhurinsky J, Shnizer D, Lando Z, Zharhary D, Kam Z, Ben-Ze'ev A and Geiger B: Regulation of S33/S37 phosphorylated β-catenin in normal and transformed cells. J Cell Sci 115: 2771-2780, 2000.
32. Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, Li Y, Lin SY and Hung MC: β-catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell 2: 323-334, 2002.